Acute complications require intravenous fluids, antibiotics, and biliary drainage (ERCP, PTC, or surgical)
Changes may be coming The FDA, under Kennedys authority, recently removed a number of experts from the compounding advisory panel
Your provider should assess your diabetes control (hemoglobin A1c), review medications, and consider testing for resistant or non-albicans Candida species or other immunocompromising conditions
Sterile handling, systematic site rotation, and consistent depth are described as the levers that actually change outcomes
In addition to weight outcomes, phase 2 data show consistent efficacy across dose groups and durations
Due to the need for once-daily injections with liraglutide and the decreased effectiveness compared to semaglutide we have opted not to offer liraglutide at this time